Selection and Interpretation of Scientific Evidence in Preparation for Policy Decisions : A Case Study Regarding Introduction of Rotavirus Vaccine Into National Immunization Programs in Sweden, Norway, Finland, and Denmark
The World Health Organization recommends inclusion of rotavirus vaccines in national immunization programs (NIPs) worldwide. Nordic countries are usually considered comparable in terms of demographics and health-care services and have comparable rotavirus disease burden. Nevertheless, the countries have reached different decisions regarding rotavirus vaccine: Norway and Finland have already introduced rotavirus vaccines into their NIPs and Sweden is currently changing its recommendation and vaccines will now be introduced on a national scale while Denmark has decided against it. This study focuses on the selection and interpretation of medical and epidemiological evidence used during the decision-making processes in Sweden, Norway, Finland, and Denmark. The so-called "severity criteria" is identified as one of the main reasons for the different policy decisions reached across the Nordic countries.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
---|---|
Enthalten in: |
Frontiers in public health - 6(2018) vom: 31., Seite 131 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
St-Martin, Gry [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Revised 01.10.2020 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fpubh.2018.00131 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM285135643 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM285135643 | ||
003 | DE-627 | ||
005 | 20231225044745.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fpubh.2018.00131 |2 doi | |
028 | 5 | 2 | |a pubmed24n0950.xml |
035 | |a (DE-627)NLM285135643 | ||
035 | |a (NLM)29868539 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a St-Martin, Gry |e verfasserin |4 aut | |
245 | 1 | 0 | |a Selection and Interpretation of Scientific Evidence in Preparation for Policy Decisions |b A Case Study Regarding Introduction of Rotavirus Vaccine Into National Immunization Programs in Sweden, Norway, Finland, and Denmark |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 01.10.2020 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a The World Health Organization recommends inclusion of rotavirus vaccines in national immunization programs (NIPs) worldwide. Nordic countries are usually considered comparable in terms of demographics and health-care services and have comparable rotavirus disease burden. Nevertheless, the countries have reached different decisions regarding rotavirus vaccine: Norway and Finland have already introduced rotavirus vaccines into their NIPs and Sweden is currently changing its recommendation and vaccines will now be introduced on a national scale while Denmark has decided against it. This study focuses on the selection and interpretation of medical and epidemiological evidence used during the decision-making processes in Sweden, Norway, Finland, and Denmark. The so-called "severity criteria" is identified as one of the main reasons for the different policy decisions reached across the Nordic countries | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Nordic countries | |
650 | 4 | |a policy decisions | |
650 | 4 | |a policy-making processes | |
650 | 4 | |a rotavirus vaccines | |
650 | 4 | |a vaccine introduction | |
700 | 1 | |a Lindstrand, Ann |e verfasserin |4 aut | |
700 | 1 | |a Sandbu, Synne |e verfasserin |4 aut | |
700 | 1 | |a Fischer, Thea Kølsen |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in public health |d 2013 |g 6(2018) vom: 31., Seite 131 |w (DE-627)NLM23377548X |x 2296-2565 |7 nnns |
773 | 1 | 8 | |g volume:6 |g year:2018 |g day:31 |g pages:131 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fpubh.2018.00131 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 6 |j 2018 |b 31 |h 131 |